Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Avacta Group Plc (AVCT.LN)

Avacta Group Plc (AVCT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avacta Group Plc Unit 20, Ash Way Thorp Arch Estate Wetherby LS23 7FA GBR

https://www.avacta.com P: 190-421-7070

Description:

Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.

Key Statistics

Overview:

Market Capitalization, $K 252,944
Shares Outstanding, K 359,042
Annual Sales, $ 23,247 K
Annual Net Income, $ -24,947 K
% of Insider Shareholders 62.19%
% of Institutional Shareholders 4.81%

Growth:

1-Year Return -25.13%
3-Year Return -46.88%
5-Year Return 194.88%
5-Year Revenue Growth 48.12%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.09
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 01/26/16

AVCT.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -123.98%
Return-on-Assets % -30.09%
Profit Margin % -107.31%
Debt/Equity 0.27
Price/Sales 8.33
Price/Book 11.60
Book Value/Share 0.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar